Cargando…
A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs
PURPOSE: Novel strategies are being applied for creating better in vitro models that simulate in vivo conditions for testing the efficacy of anticancer drugs. In the present study we developed surface-engineered, large and porous, biodegradable, polymeric microparticles as a scaffold for three dimen...
Autores principales: | Mitra, Moutushy, Mohanty, Chandana, Harilal, Anju, Maheswari, Uma K., Sahoo, Sanjeeb Kumar, Krishnakumar, Subramanian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369889/ https://www.ncbi.nlm.nih.gov/pubmed/22690114 |
Ejemplares similares
-
Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells
por: Mitra, Moutushy, et al.
Publicado: (2011) -
Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
por: Mitra, Moutushy, et al.
Publicado: (2010) -
Erratum to: Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy
por: Mitra, Moutushy, et al.
Publicado: (2011) -
EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy
por: Mitra, Moutushy, et al.
Publicado: (2012) -
Genome-wide changes accompanying the knockdown of Ep-CAM in retinoblastoma
por: Mitra, Moutushy, et al.
Publicado: (2010)